All In Biotech

Drug Trial Radar · NCT06113445

A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)

A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo

Last checked: Nov 20, 2026Latest source record: Aug 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 467 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

467

Actual

Start

Nov 29, 2023

Primary completion

Feb 24, 2026

Study completion Feb 24, 2027

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
Nov 2, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.

Conditions

  • NonSegmental Vitiligo

Interventions

  • PovorcitinibDrug

    Oral, Tablet

  • PlaceboDrug

    Oral, Tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Participants Achieving a ≥ 75% Improvement From Baseline in the Facial Vitiligo Area Scoring Index (F-VASI75)Time frame: Week 52

Locations

100 sites in 10 countries. Site status is shown where the registry gives one.

  • Cahaba Dermatology

    Hoover, Alabama

  • University of California Irvine

    Irvine, California

  • Clinical Science Institute Clinical Research Specialists Inc

    Santa Monica, California

  • Cura Clinical Research

    Sherman Oaks, California

  • Sutter Health Palo Alto Medical Foundation Pamf Sunnyvale Center

    Sunnyvale, California

  • Renaissance Research

    Cape Coral, Florida

  • Encore Medical Research, Llc

    Hollywood, Florida

  • Savin Medical Group, Rc

    Miami, Florida

  • Skin Research of South Florida, Llc

    Miami, Florida

  • San Marcus Research Clinic Inc.

    Miami Lakes, Florida

  • Olympian Clinical Research

    Tampa, Florida

  • Forcare Clinical Research

    Tampa, Florida

  • Cleaver Medical Group

    Cumming, Georgia

  • Dermatology and Surgery Specialists of North Atlanta

    Marietta, Georgia

  • Pivotal Research Solutions

    Stonecrest, Georgia

  • Options Research Group, Llc

    Kokomo, Indiana

  • Allcutis Research, Llc

    Beverly, Massachusetts

  • Metro Boston Clinical Partners

    Brighton, Massachusetts

  • Great Lakes Research Group Inc

    Bay City, Michigan

  • Wayne State University Physician Group Dermatology

    Dearborn, Michigan

  • Revival Research Institute, Llc Dermatology

    Troy, Michigan

  • Medisearch Clinical Trials

    Saint Joseph, Missouri

  • Jdr Dermatology Research

    Las Vegas, Nevada

  • Empire Dermatology

    East Syracuse, New York

  • Sadick Dermatology Sadick Research Group

    New York, New York

  • Derm Research Center of New York Inc

    Stony Brook, New York

  • Dermatology Associates of Plymouth Meeting

    Plymouth Meeting, Pennsylvania

  • International Clinical Research Tennessee Llc

    Murfreesboro, Tennessee

  • University of Texas Physicians - Bellaire Station

    Bellaire, Texas

  • Center For Clinical Studies

    Houston, Texas

  • Progressive Clinical Research

    San Antonio, Texas

  • Jordan Valley Dermatology Center

    West Jordan, Utah

  • Clinical Research Partners Llc Crp Richmond Forest Avenue Office Building Location

    Richmond, Virginia

  • Dermatology Specialists of Spokane

    Spokane, Washington

  • Hopital Universitaire de Bruxelles/ Academisch Ziekenhuis Burssel

    Brussel/ Brussels/bruxelles, Belgium

  • Universitair Ziekenhuis Gent (Uz Gent)

    Ghent, Belgium

  • Centre Hospitalier Universitaire de Liege - Sart Tilman

    Liège, Belgium

  • Cliniques Universitaires Ucl Saint-Luc

    Woluwe-Saint-Lambert, Belgium

  • Dermatology Research Institute

    Calgary, Alberta, Canada

  • Enverus Medical Research

    Surrey, British Columbia, Canada

Showing 40 of 100 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.